Biothrax: A comprehensive guide to the use, dosage, demographics, side effects, interactions, and generic options Biothrax is a vaccine used to prevent anthrax infection caused by the bacterium Bacillus anthracis. It is manufactured by Emergent BioSolutions Inc. and is the only FDA-approved vaccine for anthrax. The vaccine is administered through intramuscular injection and is given in 3 doses over 6 months. Here's everything you need to know about Biothrax: Uses: Biothrax is used to prevent anthrax infection in healthy adults aged 18 to 65 years who are at risk of exposure to anthrax. This includes individuals who work with animals or animal products, lab workers who handle anthrax, and military personnel deployed to areas where anthrax may be used as a biological weapon. Dosage: Biothrax is administered through intramuscular injection at a dosage of 0.5 mL per dose. The vaccine is given in 3 doses over 6 months with the first dose given on day 0, followed by a dose given on day 28 and a final dose given 6 months after the first dose. Demographics: Biothrax is approved for use in healthy adults aged between 18 to 65 years old who are at risk of exposure to anthrax. Pregnant or breastfeeding women and individuals with a history of anthrax infection should not receive the vaccine. Side effects: Common side effects of Biothrax include injection site pain, swelling, redness, or bruising, headache, muscle aches, fatigue, and chills. These side effects can typically be managed with over-the-counter medications and typically resolve on their own within a few days. In rare cases, Biothrax can cause serious side effects such as an allergic reaction, which may include difficulty breathing, hives, swelling of the face, throat, tongue, or lips, or a fast heart rate (tachycardia). In such cases, patients should seek immediate medical attention. Interactions: There are currently no known drug interactions with Biothrax. However, it is always important to inform your healthcare provider of any medications or supplements you are taking before receiving any vaccine. Generic Options: Biothrax is the only FDA-approved vaccine for anthrax, and there are currently no generic options available. Emergent BioSolutions Inc. has exclusive rights to manufacture and market the vaccine in the US. Conclusion: Biothrax is a safe and effective vaccine for preventing anthrax infection in healthy adults who are at risk of exposure to the bacteria. The vaccine is administered through intramuscular injection in three doses over six months. While Biothrax has some common side effects, they are generally mild and go away on their own. Patients who experience serious side effects should seek immediate medical attention. There are currently no known drug interactions with Biothrax, and there are no generic versions of the vaccine available. Remember to always speak with your healthcare provider before receiving any vaccine.